Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hyperfine, Inc. (HYPR : NSDQ)

• Company Description    Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn. Number of Employees: 136

• Price / Volume Information    Yesterday's Closing Price: $1.70 Daily Weekly Monthly 20 Day Moving Average: 138,494 shares Shares Outstanding: 71.08 (millions) Market Capitalization: $120.83 (millions) Beta: 0.28 52 Week High: $2.78 52 Week Low: $0.68 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 18.06% 13.59% 12 Week 2.41% -4.93% Year To Date 102.38% 84.09%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 351 NEW WHITFIELD STREET - GUILFORD,CT 06437 USA ph: 866-796-6767 fax: - investors@hyperfine.io https://hyperfine.io

• General Corporate Information    Officers Maria Sainz - Chief Executive Officer; President and Director R. Scott Huennekens - Executive Chairperson of the Board Jonathan M. Rothberg - Vice Chairperson of the Board Alok Gupta - Chief Financial Officer John Dahldorf - Director Peer Information Hyperfine, Inc. (ABMD) Hyperfine, Inc. (DMDS) Hyperfine, Inc. (CPWY.) Hyperfine, Inc. (EQUR) Hyperfine, Inc. (ECIA) Hyperfine, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 44916K106 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/23 Next Expected EPS Date: 08/09/23 Share - Related Items Shares Outstanding: 71.08 Most Recent Split Date: (:1) Beta: 0.28 Market Capitalization: $120.83 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.69 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/09/23

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.07 Price/Cash Flow: - Price / Sales: 15.22 EPS Growth vs. Year Ago Period: 50.00% vs. Previous Quarter: 10.53% Sales Growth vs. Year Ago Period: 74.62% vs. Previous Quarter: 85.04% ROE 03/31/23 - -47.17 12/31/22 - -50.83 09/30/22 - -54.01 ROA 03/31/23 - -43.48 12/31/22 - -46.98 09/30/22 - -49.87 Current Ratio 03/31/23 - 14.64 12/31/22 - 14.62 09/30/22 - 11.53 Quick Ratio 03/31/23 - 13.92 12/31/22 - 14.09 09/30/22 - 11.21 Operating Margin 03/31/23 - -775.18 12/31/22 - -1,073.73 09/30/22 - -1,479.40 Net Margin 03/31/23 - -775.18 12/31/22 - -1,073.73 09/30/22 - -1,479.40 Pre-Tax Margin 03/31/23 - -775.18 12/31/22 - -1,073.73 09/30/22 - -1,479.40 Book Value 03/31/23 - 1.59 12/31/22 - 1.75 09/30/22 - 1.91 Inventory Turnover 03/31/23 - 1.25 12/31/22 - 1.33 09/30/22 - 1.30 Debt-to-Equity 03/31/23 - 0.00 12/31/22 - 0.00 09/30/22 - 0.00 Debt-to-Capital 03/31/23 - 0.00 12/31/22 - 0.00 09/30/22 - 0.00

Powered by Zacks Investment Research ©